Neil Harris

Accessible vision care can lead to measurable impact. UK’s National Health Service (NHS) is rolling out digital eye screenings to primary care locations, aiming to save over 120,000 hospital visits by October 2025. This initiative not only reduces backlogs but ensures patients get the timely, life-changing care they need to prevent vision loss. More in Medical Device Network: https://lnkd.in/ewH3gwAH

15

Privileged to have had the oppertunity to join this group of experts to discuss how we can improve the outcomes of patients with Peripheral Artery Disease (#PAD) and Critical Limb Threatening Ischaemia (#CLTI), with a specific focus on reducing major limb amputations. #AbbottProud

26

A simple click to access so much useful information.

10

Cutting edge discussion on connecting medication management. Rich with real life case study on how automated medication management can move forward best patient safety, reduce avoidable errors and optimise efficiency and medicine supply. #CMM #Efficiency #MedErrors #Sustainability

9

For Healthcare Professionals Only. Interested in Antimicrobial Stewardship? Meet our Infection Prevention team during #IP2024 (September 23rd – 25th, Birmingham) to explore how our #Baxter solutions can significantly evolve your infection prevention and antimicrobial stewardship strategies. #IP2024 #AMR #InfectionPrevention #ConnectedCare #Baxter

6

De facto patient choice is much stronger in Ophthalmology as high street optometrists can generally refer directly to surgery. SpaMedica now providing c30-35% NHS funded cataract surgery.

6

Medical technology has immense potential to address the challenges facing the NHS as it grapples with long waiting times for elective care. As of November 2024, approximately 7.62 million patients in England are awaiting procedures, with a median waiting time of 14.4 weeks—nearly double the pre-COVID median of 8.0 weeks. Question, how many companies actually know the impact of their technology? I mean, really know, with peer reviewed evidence? And can actually demonstrate it’s true value to a healthcare system?

12

3 Comments

Technology has huge potential to transform healthcare, but financial challenges remain, meaning investment in new innovations is not always an option.   With the Philips UK Future Health Index 2024 finding that 77% of leaders surveyed have faced delayed, limited or no investment in medical equipment and technological solutions, the NHS urgently needs more resources to stay future-ready.   My latest Health Service Journal article explores how the NHS can overcome these funding gaps and leverage digital solutions to boost productivity and bring care closer to home.   Read it here: https://lnkd.in/enWzWDQf   #NHSfunding #leadership #healthcareinnovation

15

Abbott’s perspective highlights our commitment to diversity in clinical trials. We’re doing our part so that everyone can benefit from new medical treatments. It’s crucial for organizations across the healthcare industry to adopt more inclusive practices to improve patient outcomes across diverse populations. https://lnkd.in/gRvHHjKC #AbbottProud

3

Heard Prof Cathie Sudlow present her independent review of the UK health data landscape, commissioned by the ONS, the CMOs, NHSE and introduced on stage by Prof Chris Whitty, Dr Vin Diwaker with Prof Ian Diamond to wrap up. 💡 Chris kicked off:  there's an artificial gap between what we can do with health data (and this is widening as analytical approaches etc improve) and what we actually do, and it’s entirely within our grasp to change this. 💡 Vin stressed 2 further points: the UK has a diverse population, and in the UK we have a free NHS with a single national identifier; and this is unique in the world. 🔗 Cathie started with the two foundation components: combining the many sources of data (that includes non-NHS data) with the power of data linkage to produce transformational insights.   She concluded with 5 recommendations: 1️⃣ Recognise data as a critical national data infrastructure 2️⃣ Establish a National Health Data Service (NHDS) 3️⃣ Coordinate engagement with the public and make sure it is ongoing 4️⃣ A UK-wide approach for data access processes, with proportionate data governance 5️⃣ A UK-wide system for standards and accreditation of SDEs holding health data 🛠 The Q&A theme was strongly, ‘excellent report thankyou, lets talk details about how’.   ⚙ Some small legislative changes could be useful, but be careful to not add complexity.  ⚙ Skills and capacity needed especially in real understanding of information governance; and in data management, analysis and curation, a big shout out to data engineers ‘undervalued for far too long’ ⚙ Public conversation to be ongoing and embedded; and the public will want access to their digital data ⚙ How to construct this NHDS ?  clearly tbd, with partnerships and industry also. ⚙ Recognition of the enormous innovation in this space, and be careful to not stop that, but ensure transparency in this fast-moving space 💡 Prof Sir Ian Diamond closed with the insight: spent 50 years looking at medical reports and saying ‘if only’ (we knew some other key factor) - and now linkable data makes that a reality. Well worth a read: https://lnkd.in/esMa_eWt

13

ICYMI, here are the highlights from our ESCRS Galaxy symposium: ⬇

59

Novel bladder cancer treatment gains MHRA approval in the UK 🙏 Johnson & Johnson has announced that the MHRA has granted marketing authorisation for BALVERSA®▼ (erdafitinib) as a monotherapy for the treatment of adults with unresectable or metastatic urothelial carcinoma (UC), the most common form of bladder cancer. Specifically, the indication covers eligible patients harboring susceptible fibroblast growth factor receptor 3 (FGFR3) genetic alterations, who have previously received at least one line of therapy containing a programmed death receptor-1 (PD-1) or programmed death-ligand 1 (PD-L1) inhibitor in the unresectable or metastatic treatment setting. Approximately 10,500 people in the UK are diagnosed with bladder cancer every year, which equates to 29 people per day. Around 20 percent of people with advanced or metastatic bladder cancer have FGFR3 alterations, which can drive the growth of cancer cells > https://ow.ly/fqi750UeGws #BladderCancer #Urology #MHRA #MedicalTreatment #CancerTreatment

5

Royal Philips announced the expansion of its strategic collaboration with Amazon Web Services (AWS) to offer Philips’ integrated diagnostics portfolio in the cloud, including radiology, digital pathology, cardiology, and AI advanced visualization solutions. The collaboration aims to unify diagnostic workflows, improving access to critical insights and driving better outcomes across clinical specialties. Philips has already successfully transitioned over 150 sites across North America and Latin America to Philips HealthSuite Imaging on AWS and is building on its collaboration with AWS to accelerate the migration of health systems to the cloud, and will expand to include customer cloud migrations in Europe.    “The collaboration between Philips and AWS gives healthcare providers scalable, secure-by-design cloud-enabled solutions to accelerate healthcare innovation,” said Matt Garman, CEO of AWS. “Combining Philips’ healthcare informatics portfolio with AWS generative AI capabilities gives clinicians access to imaging insights so they can deliver more effective and efficient care to patients anywhere, anytime, with best-in-class security and privacy.” “Given the tremendous increase not only in patient volumes, but also in the complexity and number of images per study, radiologists need a tool that limits the distractions of dictation while at the same time increasing accuracy,” said Edward Steiner, Chief and Medical Director, The York/WellSpan Advanced Prostate Care Center, USA. "With Philips’ concept of ambient reporting using generative AI, you simply could speak in a conversational tone and a structured report is generated within seconds. My estimate is a 15 to 20 percent increase in efficiency, and this is just the start.” “Philips’ cloud-based healthcare informatics solutions allow us to drive better outcomes across clinical disciplines, including radiology, digital pathology and cardiology. We’re working closely with clinicians to ensure workflows become more efficient and give back valuable time to healthcare providers,” said Roy Jakobs, CEO of Royal Philips. “Collaborating with AWS helps us to innovate faster and deliver better care for more people.”   #collaboration #AmazonWebServices #AWS #Philips #radiology #digitalpathology #cardiology #AI

26

Cancer data presents a complex challenge with no easy fix.. 🔍 One major hurdle involves striking a balance between national requirements and local needs. While standardisation is vital for national-level reporting and public health strategies, it's equally important to address the unique demands of local clinical teams and individual patients. 💡 Cancer clinicians often feel that national directives fall short in capturing the nuanced data necessary for informed decision-making. This gap can hinder the adoption of personalized treatment approaches and hinder efforts to enhance patient outcomes. Additionally, many clinicians still rely on Excel spreadsheets to monitor patient cohorts due to a lack of confidence in cancer databases. 🗣️ Patients' perspectives in cancer data collection are frequently sidelined, with national surveys susceptible to selection biases. Tailoring treatment plans to individual patients, crucial for better outcomes, necessitates data that extends beyond standardized national surveys. Directly engaging with patients and leveraging digital technology can ensure their insights shape data collection efforts, resulting in more inclusive and representative systems. 🎗️ Cancer teams require comprehensive digital software solutions that streamline data collection and utilisation, accommodating insights from both national mandates and local contexts. Incorporating stakeholder feedback into the development and deployment of cancer management solutions is crucial for bridging the divide between national requirements and local clinical realities. Would love to hear your thoughts? Sally Le-Good Dr Penny Kechagioglou Gary Bee Dr Parisa Zarringhalam Philip Beak Mark Cheetham Liam Cahill #cancerwaitingtimes #cancer #fasterdiagnosis

20

1 Comment

Field Orthopaedics USA / Field Orthopaedics had another fantastic finish to the week / month welcoming Hooman Pour from BSI conducting a 4-day audit on our MDSAP and ISO13485 QA system & processes. It is great to see how we have evolved over the past 3 years passing this audit with zero observations. Thank you Hooman Pour and the entire Field Orthopaedics team for embedding QA in everything we do. Alongside our focus on making NX the gold standard for finger fractures and launching a next gen CMC Suspensionplasty System #Griplasty, one of our strategy pillars was defined around creating a QA foundation for the entire company, making sure it is not just something our VP of QA does, but rather is embedded throughout the entire organization. To all fellow CEOs, we all know the challenges of meticulous strategy execution. For us at Field Orthopaedics we tackled this 'scientifically' and made sure that [1] Strategy execution was prioritized from the top down [2] Strategy execution was addressed separately from our day-to-day operations [3] Strategy execution was supported through the right hiring and appropriate resource investment, and  [4] Strategy execution was methodically measured and analyzed throughout the organization. The below post is the article I remember reading when thinking about the task and challenges ahead, one of them changing our trajectory of QA. https://lnkd.in/gntc7-Ws #CLEAR

30

4 Comments

In today's dynamic healthcare landscape, the buzz around value-based care is palpable. It's not just about cutting costs; it's about elevating patient outcomes and experiences. As we continue to embrace patient centricity, this article I recently read highlighted some nuances of this transformative shift. From navigating the intricacies of private-public healthcare dynamics to empowering patients with agency, we need to explore the vital dimensions of 'value' in healthcare: personal, technical, and societal. But the journey doesn't end there. We're charting a course towards preventive care and effective patient engagement, fueled by interdisciplinary collaboration and innovative funding mechanisms. It truly takes a village. I'm excited to be part of this 'village' as we drive meaningful change in healthcare together. Read the full article here: https://lnkd.in/d9JPDDKv #HealthcareTransformation #ValueBasedCare #PatientEmpowerment #InterdisciplinaryCollaboration

87

1 Comment

Less than one month until Open Medical land at the Manchester Central for the #NHSConfedExpo! This is a key opportunity for us to engage with the NHS and industry leaders to discuss some of the most pressing themes in healthcare today. We look forward to exploring and elaborating on the following critical topics: 🌐 Operational Delivery We will delve into strategies for shifting care beyond hospitals to community and home settings. This approach aims to reduce healthcare disparities and by focusing on the entire patient journey, from prevention and early intervention to post-discharge care. By optimising operational delivery, we aim to create a more efficient, patient-centered healthcare system. 👨‍🔬 People We will showcase successful examples of how have ensured that healthcare delivery is sustainable and responsive to the needs of the population. 🤝 Collaboration and Partnership We will emphasise the importance of collaboration and partnership in healthcare, focusing on prevention and cross-system learning. By fostering strong relationships between various healthcare providers and stakeholders, we can achieve better health outcomes and create a more resilient healthcare system. 🏥 Health Inequalities Improvement Our focus will be on the various facets of addressing health inequalities by exploring how different initiatives within the health and social care sector are working to close the gap in health disparities, ensuring that everyone has access to high-quality care regardless of their background or socioeconomic status. 👩‍💻 Quality, Transformation, and Innovation How we are driving quality improvement and transformation across the NHS This includes implementing transormative innovative technologies, processes, and practices that can lead to more effective and efficient healthcare delivery, ultimately improving patient outcomes and system sustainability. Join us at the expo to connect, share insights, and collaborate on driving forward meaningful changes in healthcare. Lets grab a coffee! Zak Suleman Chris Ross Thomas Spector Dr Parisa Zarringhalam Will Cook Piyush Mahapatra Joseph Morris Charline Hendrickx Paul Ryan Philip Beak #NHSConfedExpo #OpenMedical #HealthcareInnovation #OperationalDelivery #WorkforceIntegration #Collaboration #HealthInequalities #Transformation #Innovation

31

Healthcare is going to look vastly different in 10 years

4